Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07240077 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia

Study acronym: BLESS
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Jan 1, 2026 to Jan 8, 2026 · Site details revised at 4 of 4 sitesv2 Show 2 more changesShow less
    • Start date changed from estimate of Jan 1, 2026 to Jan 8, 2026
    • Site details revised at 4 of 4 sites
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A double-blind randomized controlled trial comparing beta-lactam plus levofloxacin versus beta-lactam monotherapy for the treatment of Streptococcal bacteremia
Trial Details
NCT Number NCT07240077
Lead Sponsor Mahidol University
Conditions Bacteremia, Streptococcus Infection
Enrollment 165 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov